1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
FEATURED COMPANIES
- Baxter International Inc.
- GlaxoSmithKline Plc
- Pfizer Inc.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global Motion Sickness Drugs Market: About this market
Motion sickness drugs are pharmaceutical agents that are used to treat nausea and vomiting caused due to motion sickness. The motion sickness drugs market analysis considers sales from both anticholinergics and antihistamines. Our analysis also considers the sales of motion sickness drugs in Asia, Europe, North America, and ROW. In 2018, the anticholinergics segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as high demand for hyoscine hydrobromide or scopolamine for the prevention of motion sickness will play a significant role in the anticholinergics segment to maintain its market position. Also, our global motion sickness drugs market report also looks at factors such as availability of over-the-counter (OTC) drugs, availability of drugs in multiple dosage forms and growing tourism worldwide. However, nonpharmacological countermeasures to treat motion sickness, the launch of generics, side effects associated with motion sickness drugs may hamper the growth of the motion sickness drugs industry over the forecast period.
Global Motion Sickness Drugs Market: Overview
Availability of over-the-counter (OTC) drugs
The global motion sickness drugs market is predominantly served by the use of generic drugs that are available both as prescription and OTC drugs. Anticholinergics and antihistamines have been regarded as first-line therapy for suppressing and preventing the symptoms associated with motion sickness. Several antihistamines are available as OTC drugs and can be used by pediatric patients. The availability of these medicines OTC increases their accessibility and affordability and provides patients with the freedom of self-medication for the treatment of symptoms associated with minor illnesses. In addition, the availability of OTC drugs reduces the financial burden associated with medication treatment by eliminating the need for a prescription for the purchase of these drugs. This demand for over-the-counter (OTC) will lead to the expansion of the global motion sickness drugs market at a CAGR of almost 4% during the forecast period.
The advent of nauseogenic information technology
The nauseogenic information technology involves the use of nauseogenic vehicles that help in analyzing an individual's postural stability and can reveal the underlying neural or sensory-motor processes that help in achieving successful body stability. This technology revealed that motion sickness often occurs for a narrow band of frequencies of the imposed oscillation. The frequency band obtained in patients with motion sickness is similar to that produced by postural sway during the natural stance. Further advances in nauseogenic information technology are anticipated to have a positive impact on market growth.
For the detailed list of factors that will drive the global motion sickness drugs market during the forecast period 2019-2023, contact us.
Competitive Landscape
With the presence of several major players, the global motion sickness drugs market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading motion sickness drugs manufacturers, that include Baxter International Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Inc., Pfizer Inc., and Prestige Consumer Healthcare Inc.
Also, the motion sickness drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Motion sickness drugs are pharmaceutical agents that are used to treat nausea and vomiting caused due to motion sickness. The motion sickness drugs market analysis considers sales from both anticholinergics and antihistamines. Our analysis also considers the sales of motion sickness drugs in Asia, Europe, North America, and ROW. In 2018, the anticholinergics segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as high demand for hyoscine hydrobromide or scopolamine for the prevention of motion sickness will play a significant role in the anticholinergics segment to maintain its market position. Also, our global motion sickness drugs market report also looks at factors such as availability of over-the-counter (OTC) drugs, availability of drugs in multiple dosage forms and growing tourism worldwide. However, nonpharmacological countermeasures to treat motion sickness, the launch of generics, side effects associated with motion sickness drugs may hamper the growth of the motion sickness drugs industry over the forecast period.
Global Motion Sickness Drugs Market: Overview
Availability of over-the-counter (OTC) drugs
The global motion sickness drugs market is predominantly served by the use of generic drugs that are available both as prescription and OTC drugs. Anticholinergics and antihistamines have been regarded as first-line therapy for suppressing and preventing the symptoms associated with motion sickness. Several antihistamines are available as OTC drugs and can be used by pediatric patients. The availability of these medicines OTC increases their accessibility and affordability and provides patients with the freedom of self-medication for the treatment of symptoms associated with minor illnesses. In addition, the availability of OTC drugs reduces the financial burden associated with medication treatment by eliminating the need for a prescription for the purchase of these drugs. This demand for over-the-counter (OTC) will lead to the expansion of the global motion sickness drugs market at a CAGR of almost 4% during the forecast period.
The advent of nauseogenic information technology
The nauseogenic information technology involves the use of nauseogenic vehicles that help in analyzing an individual's postural stability and can reveal the underlying neural or sensory-motor processes that help in achieving successful body stability. This technology revealed that motion sickness often occurs for a narrow band of frequencies of the imposed oscillation. The frequency band obtained in patients with motion sickness is similar to that produced by postural sway during the natural stance. Further advances in nauseogenic information technology are anticipated to have a positive impact on market growth.
For the detailed list of factors that will drive the global motion sickness drugs market during the forecast period 2019-2023, contact us.
Competitive Landscape
With the presence of several major players, the global motion sickness drugs market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading motion sickness drugs manufacturers, that include Baxter International Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Inc., Pfizer Inc., and Prestige Consumer Healthcare Inc.
Also, the motion sickness drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Baxter International Inc.
- GlaxoSmithKline Plc
- Pfizer Inc.
PART 01: EXECUTIVE SUMMARYPART 07: CUSTOMER LANDSCAPEPART 09: DECISION FRAMEWORKPART 15: EXPLORE AUTHOR
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCT
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
List of Exhibits
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Baxter International Inc.
- GlaxoSmithKline Plc
- Johnson & Johnson Services Inc.
- Pfizer Inc.
- Prestige Consumer Healthcare Inc.
Note: Product cover images may vary from those shown
